Jain Global’s IDEAYA Biosciences IDYA Stock Holding History

Jain Global’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,041	Closed	-$727K	–	1415
2025 Q4	$727K	Buy	21,041 +9,281	+79%	+$296K	﹤0.01%	761
2025 Q3	$320K	Buy	+11,760	New	+$284K	﹤0.01%	809

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jain Global's IDYA Position: Q1 2026 in Review

Jain Global sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 21,041 shares — an estimated $727K sold.

Jain Global first reported a position in IDYA in Q3 2025 and held it in 2 quarters. The position peaked at $727K in Q4 2025. 254 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

Jain Global reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
Jain Global sold 21,041 IDEAYA Biosciences shares in Q1 2026, an estimated $727K.
Jain Global first reported a position in IDEAYA Biosciences in Q3 2025 and held it in 2 quarters.
Jain Global's IDEAYA Biosciences position peaked at $727K in Q4 2025.
254 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.